Delivery Order SPE2DB25D3018-SPE2DB25FUXJD

Award Date 4/25/25
Potential Completion Date 4/28/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 40 mg/0.4 mL prefilled pens. The contract has a firm fixed price of $2,188.39 and a performance period through May 1, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) 40 mg/0.4 mL pens, a medication used to treat various autoimmune conditions. The contract has a firm fixed price of $1,510.60 and a completion date of April 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) 40 mg/0.4 mL pens, a medication used to treat various autoimmune diseases. The contract has a firm fixed price of $4,518.15 and a period of performance through May 6, 2025. It is not designated as a set-aside contract, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,794.58, is for the supply of Humira (adalimumab) 40 mg/0.4 mL pens, a medication used to treat various autoimmune diseases. The contract is a firm-fixed-price delivery order, with a performance period ending on May 2, 2025. This contract is not designated as a set-aside and was...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) pens, a biologic medication used to treat various autoimmune conditions. The contract has a ceiling value of $9,550.39 and a period of performance through May 8, 2025. It is a firm-fixed-price contract, which indicates a predetermined price for the delivered...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Humira (adalimumab) pens, a biologic medication used to treat various autoimmune conditions. The contract has a firm fixed price of $15,244.92 and a performance period through May 12, 2025. This contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL pens, a medication used to treat various autoimmune conditions. The contract has a ceiling value of $6,237.00 and a performance period that runs through May 14, 2025. This award is not set-aside and is issued under a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,506.72, is for the supply of Humira (adalimumab) 40 mg/0.4 mL auto-injector pens, a specialty medication used to treat various inflammatory conditions. The contract has a firm-fixed price and an ultimate completion date of April 25, 2024. This delivery order is...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL prefilled pens, a specialty medication used to treat various autoimmune disorders. The contract has a firm fixed price of $18,693.95 and an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Humira (adalimumab) Pen 40 mg/0.4 mL. The contract has a firm fixed price of $16,552.17 and a completion date of September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
  • SPE2DB25D3018
    Indefinite Delivery Contract
  • SPE2DB25D3018-SPE2DB25FUXJD
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) 40 mg/0.4 mL prefilled pens, a biologic medication used to treat various autoimmune conditions. The contract has a firm fixed price of $2,265.90 and a performance period ending on April 28, 2025. This contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support various government healthcare programs, particularly for military and veteran populations.

Generated 7/25/25, 11:24 AM